Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Britain to extend COVID booster rollout to over-40s

CoronavirusNov 15, 2021 10:51
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. FILE PHOTO: A pharmacist prepares a COVID-19 vaccine in Northampton, Britain, October 21, 2021. REUTERS/Andrew Boyers

By Alistair Smout

LONDON (Reuters) -Britain's COVID-19 booster vaccine rollout is to be extended to people aged between 40 and 49, officials said on Monday, in a bid to boost waning immunity in the population ahead of the colder winter months.

Currently all people aged 50 and above, those who are clinically vulnerable and frontline health workers are eligible for boosters, and the Joint Committee on Vaccination and Immunisation (JCVI) said that the rollout would be extended.

The advice comes as the UK Health Security Agency released data from a real-world study which found the booster gave over 90% protection against symptomatic COVID-19 for people aged 50 and above.

Prime Minister Boris Johnson is leaning on booster vaccines and shots for children to try to withstand winter pressures on hospitals without resorting to another COVID lockdown.

"If the booster programme is successful, and with very high uptake, we can massively reduce the worry about hospitalisation and death due to COVID at Christmas, and for the rest of this winter, for literally millions of people," deputy Chief Medical Officer Jonathan Van Tam told reporters.

"It could be quite a bumpy few months ahead. But everyone has a key role to play in achieving as safe and disruption-free a winter as possible."

Health Secretary Sajid Javid said that he had accepted the recommendation, and would ask the health service to prepare to offer the vaccine to those newly eligible as soon as possible.

Britain is mainly using the Pfizer-BioNTech and Moderna (NASDAQ:MRNA) shots in the booster rollout, with people being eligible six months after their second shot.

The real-world study found that protection against symptomatic disease following a booster was 93.1% for people who were initially given AstraZeneca (NASDAQ:AZN)'s vaccine, and 94% for people who had been given the Pfizer (NYSE:PFE) shot originally.

The JCVI added that the protection given by boosters against severe disease was expected to be higher.

However, the panel declined to recommend boosters for under 40s, saying it had found no robust evidence of a decline in protection against severe COVID-19 from the original vaccine rollout in that age group.

"It may well be that adults who are under 40 years might require a booster dose or third dose at some point," Wei Shen Lim, the JCVI's Chair for COVID-19 immunisation, told reporters, adding that the committee would keep monitoring the data.

The JCVI also said that all 16 to 17 year olds would be invited to have their second dose of Pfizer vaccine, having previously advised that they only receive an initial shot unless they had an underlying health condition.

Britain to extend COVID booster rollout to over-40s
 

Related Articles

Britain reports 70,924 new COVID-19 cases, 88 deaths
Britain reports 70,924 new COVID-19 cases, 88 deaths By Reuters - Jan 16, 2022

LONDON (Reuters) - Britain reported 70,924 new cases of COVID-19 on Sunday and 88 deaths within 28-days of a positive test. That compares with 81,713 new cases on Saturday, and...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (1)
paul gingell
paul gingell Nov 15, 2021 9:45
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Totally Agree with this decision.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email